Direct costs of relapses in patients with relapsing-remitting multiple sclerosis

Autor: Ll. Ramió-Torrentà, G. Martín, L. Gubieras, M.A. Mañé-Martínez, I. Bonaventura, Luis Brieva, Elvira Munteis, M. Hervas, J.J. Hernández, V. Casado, S. Martínez-Yélamos, S. Presas-Rodriguez, A. Escartin

Publikováno v: Neurology Perspectives. 1:160-169

Introduction Effective treatments that reduce relapses can diminish the impact on MS costs in the long-term. This study aims to estimate direct costs of RRMS relapses in Catalonia (Spanish region). Methods Multi-centre, prospective, cross-sectional o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d69afa5f76ca1dd418fa4a365ec3e0a
https://doi.org/10.1016/j.neurop.2021.05.003

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

Autor: Cristina Ramo-Tello, Georgina Arrambide, Sergio Martínez-Yélamos, Nuria Sola-Valls, Albert Saiz, Maria Alba Mañé-Martínez, Antonio Escartin, L Romero-Pinel, Nicolau Ortiz, Susana Otero-Romero, Xavier Montalban, Emili Vela, Javier Sotoca, Luis Brieva, Mariona Hervás, Jaume Sastre-Garriga, Yolanda Blanco, Raul Pelayo, Mar Tintoré, Maria Sepúlveda, L. Gubieras, Thaís Armangue, René Robles-Cedeño, Sara Llufriu, Lluís Ramió-Torrentà, Antonio Cano, Francesc Graus, Elvira Munteis, Silvia Presas-Rodríguez, Marta Aldea, Domingo Escudero

Publikováno v: MULTIPLE SCLEROSIS JOURNAL
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Multiple Sclerosis Journal
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu

Background: Population-based studies on neuromyelitis optica spectrum disorders (NMOSD) are limited, and it is unclear whether the rates have changed with the implementation of the new 2015 criteria. Objectives: To estimate the incidence and prevalen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdfab6947752d759bc350364dd5e7689
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13077

HLA‐DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population

Autor: C. Azqueta, E. Matas, T. Arbizu, S. Martínez-Yélamos, J. M. Pujal, L. Gubieras, L. Bau, M. Torrabadella, L. Romero-Pinel

Publikováno v: European Journal of Neurology. 18:337-342

Background and objective: The association of HLA-DRB1*15 with susceptibility to multiple sclerosis (MS) has been consistently reported although its effect on the clinical phenotype is still controversial. The objectives of this study are to investiga

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0db23c466cf742e0cfc88d675495435b
https://doi.org/10.1111/j.1468-1331.2010.03148.x

Adult herpes simplex encephalitis: Fifteen years’ experience

Autor: Sergio Martínez-Yélamos, Carmen Cabellos, Pedro Fernández-Viladrich, A. Riera-Mestre, L. Gubieras

Publikováno v: Enfermedades Infecciosas y Microbiología Clínica. 27:143-147

Introduction: Herpes simplex encephalitis (HSE) is the most frequent cause of sporadic necrotizing encephalitis in adults. The aim of this study is to describe the characteristics of HSE and the factors influencing its outcome. Material and methods:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc902baf26271b23947d833f08943553
https://doi.org/10.1016/j.eimc.2008.05.006

Anticipation of age at onset in multiple sclerosis: methodologic pitfalls

Autor: J. M. Ramón, Carmona O, E. Moral, Lucia Alonso-Magdalena, S. Martínez-Yélamos, T. Arbizu, L. Gubieras, L. Romero-Pinel

Publikováno v: Acta Neurologica Scandinavica. 121:426-428

Background/aim - There are several reports that claim anticipation in complex or polygenic diseases such as multiple sclerosis (MS), Crohn disease or schizophrenia. The aim of the present study was to assess age at onset of MS during the last 60 year

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70e97c37d94b61daca140e4f017fc5f4
https://doi.org/10.1111/j.1600-0404.2009.01273.x